日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Quantitative Comparison of Two Novel Swept-Source Optical Coherence Tomography Angiography Devices

两种新型扫频源光学相干断层扫描血管造影设备的定量比较

Hafner, Michael; Deschler, Daniel J P; Kufner, Alexander; Katscher, Lisa M; Priglinger, Siegfried G; Gerhardt, Maximilian J

Mechanisms of Gas-Induced Posterior Vitreous Detachment: A Look Behind the Bubble Using Optical Coherence Tomography in Prone Position

气体诱发后玻璃体脱离的机制:俯卧位光学相干断层扫描揭示气泡背后的真相

Klaas, Julian Elias; Siedlecki, Jakob; Schworm, Benedikt; Feucht, Nikolaus; Maier, Mathias; Priglinger, Siegfried G

Topiramate-induced acute angle closure with suprachoroidal effusion: Insights from a novel ultra-wide-field OCT device

托吡酯诱发的急性闭角型青光眼伴脉络膜上腔积液:来自新型超广角OCT设备的启示

Hafner, Michael; Pensel, Nicolas; Scherer, Nicolas C D; Mackert, Marc J; Priglinger, Siegfried G; Keidel, Leonie F; Gerhardt, Maximilian J

Quantifying segmentation sensitivity in OCTA: Device-specific profiles across three commercial platforms

量化OCTA中的分割敏感性:三个商业平台上的设备特定特征

Hafner, Michael; von Livonius, Bettina; Deschler, Daniel; Priglinger, Siegfried G; Gerhardt, Maximilian J

Role of Endogenous Galectin-3 on Cell Biology of Immortalized Retinal Pigment Epithelial Cells In Vitro

内源性半乳糖凝集素-3在体外永生化视网膜色素上皮细胞生物学中的作用

Liesenhoff, Caspar; Hillenmayer, Marlene; Havertz, Caroline; Geerlof, Arie; Hartmann, Daniela; Priglinger, Siegfried G; Priglinger, Claudia S; Ohlmann, Andreas

Suprachoroidal implantation of corticosteroid slow release implants for the treatment of cystoid macular edema

脉络膜上腔植入缓释皮质类固醇植入物治疗囊样黄斑水肿

Asani, Ben; Kruse, Franziska; Siedlecki, Jakob; Schiefelbein, Johannes Benedikt; Schworm, Benedikt; Klaas, Julian; Herold, Tina; Priglinger, Siegfried G

Quantitative comparison of a novel swept-source optical coherence tomography angiography device with three established systems

对一种新型扫频源光学相干断层扫描血管造影设备与三种已建立的系统进行定量比较

Hafner, Michael; Priglinger, Siegfried G; von Livonius, Bettina; Gerhardt, Maximilian J

High-Dose 8 mg Aflibercept for Neovascular Age-Related Macular Degeneration: Who Is Being Treated with This New Agent?

高剂量 8 毫克阿柏西普治疗新生血管性年龄相关性黄斑变性:哪些患者正在接受这种新药治疗?

Liesenhoff, Caspar; Meyrl, Carolin; Krause, Daniel; Eckardt, Franziska; Lorger, Anna; Deiters, Viktoria; Schiefelbein, Johannes; Klaas, Julian Elias; Schworm, Benedikt; Priglinger, Siegfried G; Siedlecki, Jakob

Deep-Learning-Assisted Analysis of Early Biomarker Changes in Treatment-Naïve Patients with Neovascular AMD Under Intravitreal Faricimab

利用深度学习辅助分析初治新生血管性年龄相关性黄斑变性患者在玻璃体内注射法瑞西单抗治疗后早期生物标志物的变化

Hafner, Michael; Asani, Ben; Eckardt, Franziska; Siedlecki, Jakob; Schworm, Benedikt; Priglinger, Siegfried G; Schiefelbein, Johannes

Real-World Data on Morphological and Functional Responses After Switching to Faricimab in Recalcitrant, Chronic Diabetic Macular Edema

难治性慢性糖尿病性黄斑水肿患者改用法瑞西单抗后形态学和功能反应的真实世界数据

Deiters, Viktoria; Lorger, Anna; Eckardt, Franziska; Siedlecki, Jakob; Schworm, Benedikt; Priglinger, Siegfried G; Herold, Tina R